18F-FDG and 18F-Fluorocholine PET as Prognostic Biomarkers in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Prospective Multicenter Study.

Saved in:
Bibliographic Details
Title: 18F-FDG and 18F-Fluorocholine PET as Prognostic Biomarkers in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Prospective Multicenter Study.
Authors: Cochet A; Université Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, Department of Nuclear Medicine, ICMUB, UMR CNRS 6302, Dijon, France; acochet@cgfl.fr., Besson V; Université Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, Department of Nuclear Medicine, ICMUB, UMR CNRS 6302, Dijon, France., Bertaut A; Université Bourgogne Europe, Centre Georges-François Leclerc, Methodology and Biostatistics Unit, Dijon, France., Fouquier A; Université Bourgogne Europe, Centre Georges-François Leclerc, Methodology and Biostatistics Unit, Dijon, France., Vrigneaud JM; Université Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, Department of Nuclear Medicine, ICMUB, UMR CNRS 6302, Dijon, France., Bronowicki JP; Department of Gastro-Enterology and Hepatology, University Hospital of Nancy, Nancy, France., Chevalier E; Department of Nuclear Medicine, University Hospital of Nancy, Nancy, France., Heurgue A; Department of Hepato-Gastro-Enterology, University Hospital of Reims, Reims. France., Papathanassiou D; Department of Nuclear Medicine, Institut Jean Godinot, Reims, France.; CRESTIC, University of Reims Champagne-Ardenne, Reims, France., Blanc JF; Department of Hepato-Gastro-Enterology, University Hospital of Bordeaux, Bordeaux, France., Pinaquy JB; Department of Nuclear Medicine, University Hospital of Bordeaux, Bordeaux, France., Vincent J; Université Bourgogne Europe, Centre Georges-François Leclerc, Department of Medical Oncology, Dijon, France., Palard-Novello X; CLCC Eugène Marquis, INSERM, LTSI-UMR 1099, University of Rennes, Rennes, France., Bourien H; Department of Medical Oncology, Centre Eugene-Marquis, Rennes, France; and., Tabouret-Viaud C; Université Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, Department of Nuclear Medicine, ICMUB, UMR CNRS 6302, Dijon, France., Manfredi S; Université Bourgogne Europe, University Hospital of Dijon, Department of Hepato-Gastro-Enterology, Dijon, France.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 Apr 30. Date of Electronic Publication: 2026 Apr 30.
Publication Type: Journal Article
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1535-5667
DOI:10.2967/jnumed.125.271382